Related Experiment Video

Updated: Oct 20, 2026

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

24.2K

Emerging Strategies and Challenges for Controlled Delivery of Taxanes: A Comprehensive Review

Mohit Mahajan, Rajneet Kaur Khurana, Nikhil Shri Sahajpal

  • 1Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar [Punjab] 143 005 INDIA. subheetjain.pharm@gndu.ac.in.

Current Drug Metabolism
|August 13, 2015
PubMed

Insights

Controlled drug delivery systems significantly improve cancer treatment with taxanes by overcoming limitations. These advanced systems enhance drug absorption, reduce toxicity, and improve cellular uptake for better therapeutic outcomes.

Area of Science:

  • Pharmacology and Pharmaceutical Sciences
  • Oncology
  • Biomedical Engineering

Background:

  • Taxanes revolutionized cancer therapy in the mid-1990s, but conventional delivery methods present significant limitations.
  • Challenges include pharmacokinetic constraints, drug resistance, and toxicity, hindering optimal therapeutic potential.
  • Controlled drug delivery systems offer a promising avenue to enhance taxane efficacy and safety.

Purpose of the Study:

  • To review the advancements in controlled drug delivery systems for taxanes.
  • To analyze how these systems alter pharmacokinetic and pharmacodynamic profiles.
  • To highlight improvements in toxicity, absorption, and cellular uptake, and discuss clinical and commercial aspects.

Main Methods:

  • Comprehensive literature review of controlled drug delivery systems for taxanes.
  • Analysis of various nanocarrier systems including liposomes, solid lipid nanoparticles, nanoemulsions, nanocapsules, hydrogels, and micelles.
  • Evaluation of pharmacokinetic, pharmacodynamic, and toxicity data from existing studies.

Main Results:

  • Controlled delivery systems significantly alter taxane absorption, resistance, and cellular uptake.
  • Various carrier systems demonstrate improved safety profiles and enhanced therapeutic responses compared to conventional methods.
  • Specific examples of nanocarriers show promise in overcoming delivery challenges.

Conclusions:

  • Controlled drug delivery systems represent a significant advancement in optimizing taxane-based cancer therapy.
  • These systems offer improved efficacy, reduced toxicity, and better patient outcomes.
  • Further research into clinical applications and commercialization of these advanced delivery systems is warranted.

More Related Videos

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

8.0K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.2K

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...